wawang anwarudin (2026) “Cost-Effectiveness Analysis of Rifampicin and Bedaquiline Use for Tuberculosis Treatment: A Systematic Review”, Journal of Health Economic and Policy Research (JHEPR), 4(1), pp. 95–103. doi: 10.30595/jhepr.v4i1.442.